Skip to content

An assessment by measurement (measuring arm) on the effects of a Footjacks flat orthotic compared to a flat insole and a standard orthotic on the lower limb, pelvis and spine together with the wearing effects (wearing arm) over a seven month period on adults with chronic low back pain compared to a flat control insole

An assessment of the effects Footjack flat orthotic on (1) the foot, lower limbs, pelvis, and spine compared to a control and a standard arch support and (2) on pain and function in subjects with pes planus and chronic low back pain over a 7 month period compared to a control with random allocation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN37543220
Enrollment
81
Registered
2017-08-23
Start date
2017-08-24
Completion date
Unknown
Last updated
2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pes planus Musculoskeletal Diseases Flat foot [pes planus] (acquired)

Interventions

Wearing arm Participants will be selected from the Chief Investigator’s osteopathic patients. A trial case history will be taken to determine that they are eligible for the trial. Writ

Sponsors

Footjacks Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Wearing arm: 1. Age 18-75 2. Iliac crests not level with easy normal standing with feet straight and iliac crests level or substantially level when standing on lateral calcanei 3. Chronic low back pain (three episodes of back pain in the last 24 months with pain at the time consent taken) below T12, including lumbar spine and pelvic joints with or without radiating pain Measuring arm: 1. Age 18 to 75 2. Iliac crests not level by at least 1.5 degrees with easy normal standing with feet straight and iliac crests level or substantially level when standing on the lateral calcanei

Exclusion criteria

Exclusion criteria: Wearing arm: 1. Under 18 and over 75 2. No history of chronic low back pain 3. Lack of suitability for whatever clinical reason to be randomised (any condition in the opinion of the Investigator would make it unsafe or unsuitable for the patient to participate in the study) 4. Person unable to give consent 5. Vulnerable people 6. Patient with any musculoskeletal condition making it difficult for the spine to adapt to a change, e.g. spinal fusion in the neck, disc herniation threatening the cord, severe spinal stenosis etc. Subject will complete a case history at the assessment stage of the trial and excluded if unsuitable for the trial due to such a condition 7. Severe sciatica with neurological signs 8. Cancer 9. Pregnancy or planned pregnancy 10. Severe osteoarthritis of lower limb joints 11. Inflammatory arthritis 12. Recent or complicated fractures 13. Congenital lower limb deformity 14. Undertaking a course of medical treatment or physical therapy of more than 1 a month that could interfere with the validity of the trial data 15. Foot pathology which interferes with levelling of the pelvis 16. Already wearing standard arch supports 17. Progressive and/ or severe multiple sclerosis Measuring arm: 1. Musculoskeletal system is unable to adjust to changes in movement through the lower limb, pelvis and spine 2. Subjects being unlevel at the iliac crests of less than 1.5 degrees using the Palm Inclinometer 3. A congenital lower limb deformity 4. Any balance problem making difficult to stand on one leg 5. Anyone who is unable to follow the necessary instructions. They will not be excluded if they have a family member who can explain/translate

Design outcomes

Primary

MeasureTime frame
Wearing arm: Level of pain and physical functioning as determined by the Oswestry Low Back Disability Questionnaire at baseline and at the end of 1, 2, 3, 5 and 7 months Measuring arm: Levelness or substantial levelness of the iliac crests with or without pelvic translation. Measurements will be taken on the three footbeds in easy normal standing with the feet pointing straight where the iliac crests are not otherwise level in bare feet in the same stance. The measurements will be compared to the position of the iliac crests when standing in the same stance with the centre of pressure on the lateral aspect of the calcanei.

Secondary

MeasureTime frame
Wearing arm: 1. Safety and adverse events. Subjects will be asked to report adverse events that are not expected at baseline and at the end of the 1, 2, 3, 5 and 7 months. Subjects will be asked to advise of unusual, unexpected or persistent adverse events as they occur so that appropriate action can be taken. 2. Usual pain in the last week, measured using a VAS assessment at inception and at the end of 1st, 2nd, 3rd, 5th and 7th months 3. Stability in high heel shoes (women only), measured using VAS assessment at inception, and at the end of 1st, 2nd, 3rd, 5th and 7th months 4. Comfort, measured using a VAS assessment at inception, and at the end of 1st, 2nd, 3rd, 5th and 7th months 5. Significant global improvement, measured using a VAS assessment at the end of 1st, 2nd, 3rd, 5th and 7th months 6. Function in the lower limb, measured using the Lower Extremity Functional Scale at the end of the 1st, 2nd, 3rd 5th and 7th months Measuring arm: 1. Levelness or substantial levelness of the ASIS’s in the coronal plane in the same stance as in 1.above with or without pelvic translation testing the three footbeds in easy normal bilateral standing and comparing the same to their levelness when standing in the same stance with the centre of pressure on the lateral calcanei 2. The rotational attitude of HAT (Head, Arms and Thorso) in the coronal plane as measured just below the xiphoid process standing on the most collapsing calcaneus in the transverse/coronal planes in unilateral stance and the foot placed straight at mid stance. The degree of rotation, whether left or right, should substantially approximate that as measured when standing on the same calcaneus at mid stance on a bare foot and standing with the foot on the ground and standing on the lateral aspect of the calcaneus, on a straight placed foot 3. Preven

Countries

United Kingdom

Contacts

Public ContactMark Stern
markstern34@gmail.com+44 (0)192 383 9906

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026